Lineage Cell Therapeutics (LCTX) Invested Capital (2014 - 2023)
Lineage Cell Therapeutics' (LCTX) quarterly Invested Capital came in at $152000.0 in Q3 2023, up 270.73% year-on-year from $41000.0 in Q3 2022, and down 8.98% quarter-over-quarter from $167000.0 in Q2 2023.
Lineage Cell Therapeutics (LCTX) Invested Capital (2014 - 2023) Analysis & Trends
Lineage Cell Therapeutics' Invested Capital history runs 7 years deep, the most recent figure standing at $152000.0 for Q3 2023.
- On a quarterly basis, Invested Capital rose 270.73% year-over-year to $152000.0 in Q3 2023; TTM through Jun 2024 was $152000.0, a 69.9% decrease from a year earlier, with the FY2022 full-year figure at $113000.0, up 213.89% from the prior year.
- Invested Capital retreated to $152000.0 in Q3 2023 per LCTX's latest filing, from $167000.0 in the prior quarter.
- Across five years, Invested Capital topped out at $184000.0 in Q1 2023 and bottomed at $29000.0 in Q3 2021.
- The 5-year median for Invested Capital is $75000.0 (2020), against an average of $85500.0.
- Across the five-year window, Invested Capital sank 64.52% in 2021 and jumped 270.73% in 2023, its largest moves.
- Year by year, Invested Capital stood at $110000.0 in 2019, then slumped by 61.82% to $42000.0 in 2020, then slipped by 14.29% to $36000.0 in 2021, then surged by 213.89% to $113000.0 in 2022, then jumped by 34.51% to $152000.0 in 2023.
- Per Business Quant, the three latest LCTX Invested Capital figures stand at $152000.0 (Q3 2023), $167000.0 (Q2 2023), and $184000.0 (Q1 2023).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | 110.96 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 116.14 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Lineage Cell Therapeutics | 251.15 Mn | 188.44 Mn | 1.73 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 152,000.00 |
| Jun 30, 2023 | 167,000.00 |
| Mar 31, 2023 | 184,000.00 |
| Dec 31, 2022 | 113,000.00 |
| Sep 30, 2022 | 41,000.00 |
| Jun 30, 2022 | 48,000.00 |
| Mar 31, 2022 | 57,000.00 |
| Dec 31, 2021 | 36,000.00 |
| Sep 30, 2021 | 29,000.00 |
| Jun 30, 2021 | 33,000.00 |
| Mar 31, 2021 | 42,000.00 |
| Dec 31, 2020 | 42,000.00 |
| Sep 30, 2020 | 44,000.00 |
| Jun 30, 2020 | 93,000.00 |
| Mar 31, 2020 | 102,000.00 |
| Dec 31, 2019 | 110,000.00 |
| Sep 30, 2019 | 120,000.00 |
| Jun 30, 2019 | 126,000.00 |
| Dec 31, 2015 | 33,800.00 |
| Jun 30, 2015 | 3,000.00 |